The CCN family of matricellular proteins are recognized bona fide targets for therapeutically targeting so-called chronic inflammatory diseases, including fibrosis and cancers. The majority of the work supporting this contention has been derived from examining CCN2, formerly, and unhelpfully, termed "connective tissue growth factor." Both CCN2, and its related protein, CCN1, formerly termed "cysteine-rich protein 61", are positively regulated by not only TGFbeta, but also by the hippo/YAP/ TAZ mechanotransduction pathway that appears to drive these pathologies. Indeed, increasing evidence indicates that CCN1 also contributes to these fibrosis and cancers and, consequently, targeting both CCN2 and CCN1 simultaneously could be of therapeutic value. This commentary focuses on a recent, exciting paper (Ju et al., 2020, Scientific Reports, 10, 3201) suggesting that CCN1 is a target for non-alcoholic steatohepatitis (NASH).Keywords CCN1 . Cyr61 . CCN family . NASH . Non-alcoholic steatohepatitis . Fibrosis . Steatosis . Matricellular proteins Non-alcoholic fatty liver disease (NAFLD), a liver disease affecting people who drink little to no alcohol, is characterized by the excessive storage of fat in liver cells. NAFLD is the most common liver disease in Canada affecting about 20% of Canadians. The most common cause of NAFLD is obesity. Certain conditions that often accompany and may contribute to fatty liver disease include: diabetes mellitus, hyperlipidemia, insulin resistance and high blood pressure.Non-alcoholic steatohepatitis (NASH), a serious form of NAFLD, is characterized by liver fibrosis and cirrhosis. In most cases, NASH seems to be a slowly progressive disease. However, NASH patients can have liver cancer or liver failure and an increased risk of cardiovascular disease and diabetes. Inflammation in the liver plays a critical role in the development of NASH, and NASH-associated liver fibrosis. However, the underlying mechanisms have not been completely elucidated.The CCN family, including CCN1 [cysteine-rich protein 61 (Cyr61)], CCN2 (connective tissue growth factor), and CCN3 (nephroblastoma overexpressed), are matricellular proteins that play critical roles in development, differentiation,